Study of SYN818 for the Treatment of Advanced or Metastatic Solid Tumors

Abroad (travel likely)RecruitingPHASE1

Conditions

Advanced Solid Cancer · Metastatic Solid Tumor · Ovarian Cancer · Breast Cancer · Prostate Cancer · BRCA Mutation · HRR Deficiency

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Henan Cancer Hospital, Zhengzhou, Henan, China
Contact: Study coordinator (Min Yan, MD, PhD) · ym200678@126.com · +86-371-65588007
Fudan University Shanghai Cancer Center., Shanghai, Shanghai Municipality, China
Contact: Study coordinator (Hongxia Wnag, MD, PhD) · whx365@126.com · +86-21-64175590

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

DXP-106 in Solid Tumor Patients.

Solid Tumor · Cancer

Abroad (travel likely)RecruitingPHASE1

Harbin, China · Shanghai, China

A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations

Cancer · PDAC - Pancreatic Ductal Adenocarcinoma · NSCLC (Non-small Cell Lung Cancer)

Abroad (travel likely)RecruitingPHASE1

Orlando, United States · Boston, United States

A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors

Advanced or Metastatic Solid Tumors · Triple Negative Breast Cancer (TNBC) · HR+ Breast Cancer

Abroad (travel likely)RecruitingPHASE1

Denver, United States · Houston, United States

A Study of BL-B16D1 in Patients With Unresectable Locally Advanced or Metastatic Breast Cancer and Other Solid Tumors

Breast Cancer · Solid Tumor

Abroad (travel likely)RecruitingPHASE1

Shanghai, China